MLS-101
Mineralys Therapeutics
[]
$mlys - mineralys therapeutics presents positive lorundrostat results from the phase 2 target-htn trial at acc.23/wcc 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.